These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37238737)
21. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response. Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984 [TBL] [Abstract][Full Text] [Related]
22. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis. Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059 [TBL] [Abstract][Full Text] [Related]
24. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050 [TBL] [Abstract][Full Text] [Related]
25. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress. Wei K; Wei Y; Xu W; Lu F; Ma H Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139 [TBL] [Abstract][Full Text] [Related]
26. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice. Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847 [TBL] [Abstract][Full Text] [Related]
28. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005 [TBL] [Abstract][Full Text] [Related]
29. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086 [TBL] [Abstract][Full Text] [Related]
30. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Yin X; Liu Z; Wang J Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090 [TBL] [Abstract][Full Text] [Related]
31. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
32. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120 [TBL] [Abstract][Full Text] [Related]
33. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523 [TBL] [Abstract][Full Text] [Related]
34. N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice. Bhagat HA; Compton SA; Musso DL; Laudeman CP; Jackson KMP; Yi NY; Nierobisz LS; Forsberg L; Brenman JE; Sexton JZ PLoS One; 2018; 13(10):e0204605. PubMed ID: 30359371 [TBL] [Abstract][Full Text] [Related]
35. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. Rabinowich L; Fishman S; Hubel E; Thurm T; Park WJ; Pewzner-Jung Y; Saroha A; Erez N; Halpern Z; Futerman AH; Zvibel I J Hepatol; 2015 Jan; 62(1):175-81. PubMed ID: 25173968 [TBL] [Abstract][Full Text] [Related]
37. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855 [TBL] [Abstract][Full Text] [Related]
38. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944 [TBL] [Abstract][Full Text] [Related]
39. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1. Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491 [TBL] [Abstract][Full Text] [Related]
40. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]